Dentons Adds Schevon Salmon As Health Care Partner In Washington, D.C.

Dentons has expanded its U.S. Health Care practice by adding Schevon Salmon as a partner in Washington, D.C., bringing experience in Food and Drug Administration regulatory matters and transactions involving pharmaceutical, biotechnology, and medical device companies.

Salmon advises life sciences companies on FDA regulatory and corporate transactional matters throughout the product lifecycle, from product development and manufacturing through commercialization.

His practice includes product development, advertising and promotion, medical communications, good manufacturing practices for pharmaceuticals and medical devices, and the negotiation of quality and supply agreements.

The addition is designed to expand Dentons’ ability to advise pharmaceutical, biotechnology, and medical device businesses on regulatory, compliance, and transactional issues that arise as products progress from development toward the market.

Before joining Dentons, Salmon served as corporate counsel for a global pharmaceutical company. In that role, he advised senior executives on strategic, risk-focused legal, regulatory, and compliance matters tied to product development, manufacturing, and promotion.

Earlier in his career, Salmon worked at a regulatory-focused boutique law firm. There, he advised clients on regulatory classification, marketing, compliance, and enforcement matters involving multiple federal agencies.

Those agencies included the FDA, U.S. Department of Agriculture, U.S. Customs and Border Protection, and the Environmental Protection Agency, giving Salmon experience across several regulatory frameworks that can intersect with pharmaceutical, biotechnology, medical device, manufacturing, and commercialization activities.

Dentons said Salmon’s combination of in-house and outside counsel experience strengthens its ability to work with both emerging and established healthcare and life sciences companies. His practice complements the firm’s existing capabilities as clients manage changing regulatory expectations throughout product development, manufacturing, marketing, and commercialization.

KEY QUOTE:

“Schevon brings extensive health care regulatory experience informed by in-house and outside counsel roles with pharmaceutical and medical device companies. As our clients navigate a rapidly evolving regulatory landscape for health care and life sciences products, Schevon’s experience advising emerging and established companies will further strengthen our ability to support clients at every stage of commercialization.”

Chris Janney, Co-Leader Of Dentons’ Health Care Practice